Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease

Background Acute exacerbation of interstitial lung disease (AE-ILD) is a severe complication with a poor prognosis. No clinical trials have supported the use of rituximab in AE-ILD associated with connective tissue disease.Methods We present a series of four cases in which administration of rituxima...

Full description

Bibliographic Details
Main Authors: Francisco León Román, Beatriz Pintado-Cort, Diana García-Casado, Francisco Muñiz-González, José Antonio López García-Asenjo, Cristina Díaz-Rodríguez, María Nieves Montoro-López, Mauricio Loucel-Bellino, Beatriz Recio-Moreno, Sara Rebollo-Garrido, Yaiza Martínez-Hernández, Ivan Cusacovich
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003479.full

Internet

https://rmdopen.bmj.com/content/9/3/e003479.full

Similar Items